Related Experiment Video

Updated: Feb 17, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

14.0K

BRCA and lynch syndrome-associated ovarian cancers behave differently

Neil A J Ryan1,2, James Bolton3, Rhona J McVey3

  • 1Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, UK.

Gynecologic Oncology Reports
|December 6, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Related Experiment Videos

Last Updated: Feb 17, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

14.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K

Articles linked to this work by shared authors, journal, and citation graph.

The impact of coding germline variants on contralateral breast cancer risk and survival.

American journal of human genetics·2023

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Research square·2023

Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).

British journal of cancer·2023

Increased Circulating Chemokines and Macrophage Recruitment in Growing Vestibular Schwannomas.

Neurosurgery·2023

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.

European journal of human genetics : EJHG·2023

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry.

Genome medicine·2023

Peri-treatment ctDNA dynamics in locally advanced cervical cancer: pilot study from a safety-net hospital.

Gynecologic oncology reports·2026

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer.

Gynecologic oncology reports·2026

Real-world efficacy and safety of cemiplimab in Japanese patients with recurrent or metastatic cervical cancer: A single-center retrospective cohort study.

Gynecologic oncology reports·2026

Impact of preserving circumflex iliac nodes distal to the external iliac nodes (CINDEIN) on prognosis in low-risk endometrial cancer patients.

Gynecologic oncology reports·2026

Trends in estrogen replacement therapy use among younger gynecologic cancer survivors, 2013-2021.

Gynecologic oncology reports·2026

Concordance of folate receptor expression in ovarian cancer over time: A single-institution retrospective study.

Gynecologic oncology reports·2026

Microenvironment-adaptive drug delivery systems for ulcerative colitis: from pathological constraints to rational design.

Expert opinion on drug delivery·2026

Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review).

Oncology reports·2026

Influence of Exosomes on Tumorigenic Behavior in Triple-Negative Breast Cancer Cells through STAT3 Inhibition in Autophagy.

Asian Pacific journal of cancer prevention : APJCP·2026

Brain cannabinoid CB1 receptor signaling modulates reward responses and inhibitory control in humans.

Imaging neuroscience (Cambridge, Mass.)·2026

Recent advancement in inflammatory biomarkers for cervical cancer diagnosis and therapy.

Frontiers in oncology·2026

A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us